Impact of Systematic Tracking of Dementia Cases on the Rate of Hospitalization in Emergency Care Units (IDEM)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01569997 |
Recruitment Status :
Completed
First Posted : April 4, 2012
Last Update Posted : July 29, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Introduction: Epidemiological data show that in France only half of patients with Alzheimer disease are currently diagnosed in the general population. The absence of early diagnosis of dementia reduces the opportunities of patients to receive optimal care. One of the consequences of undiagnosed dementia is inadequate use of emergency care units.
The main objective: The main aim of this study is to evaluate the impact of a systematic case-finding procedure of dementia cases in nursing homes through a MDTM on the rate of hospitalization in emergency care units.
Secondary objectives:
To assess the impact of systematic tracking of dementia cases on the:
- Quantity and quality of drug-prescription
- Appropriateness of hospitalizations
- Prevalence of neuropsychiatric symptoms
- Dependency
- Quality of life
- Burden of nursing staff working conditions
- Planning of specific therapeutic measures
- Overall health care costs
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dementia in Nursing Home | Other: MultiDisciplinary Team Meetings (MDTM) | Not Applicable |
This is a multicentre, cluster randomized study comparing two parallel groups:
- Intervention group: nursing homes whose residents benefit from MDTM to identify the cases of dementia and to propose an adequate care project
- Control group: nursing homes whose residents continue to benefit from usual care In each group, 1000 elderly subjects aged over 60 years without documented diagnosis of dementia will be included and monitored for a period of 18 months.
Information about the main and secondary aims will be collected monthly through online questionnaires.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1428 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Interest of Systematic Tracking of Dementia Cases in Nursing Homes: Analysing the Contribution of MultiDisciplinary Team Meeting (MDTM) in Alzheimer's Disease and Related Diseases |
Study Start Date : | May 2010 |
Actual Primary Completion Date : | September 2013 |
Actual Study Completion Date : | September 2013 |

Arm | Intervention/treatment |
---|---|
Intervention group
Intervention group: nursing homes whose residents benefit from MDTM to identify the cases of dementia and to propose an adequate care project
|
Other: MultiDisciplinary Team Meetings (MDTM)
The MDTM, between the memory experts and Nursing Home coordinating practitioners, could help the nursing home medical staff identify the cases of dementia and propose these residents an adequate healthcare project (supplementary investigations, therapeutic modifications, hospitalizations...) |
No Intervention: control group
Control group: nursing homes whose residents continue to benefit from usual care
|
- Incidence of hospitalizations in emergency care units [ Time Frame: 18 months ]Monthly collection during follow-up (18 months)
- Prevalence of antipsychotic prescription [ Time Frame: Baseline visit, 4 months, 18 months ]
- Incidence of inappropriate hospitalizations [ Time Frame: 18 months ]Monthly collection during follow-up (18 months)
- Prevalence of neuropsychiatric symptoms evaluated by NPI-nursing staff version [ Time Frame: Baseline visit, 18 months ]
- Dependency evaluated by AGGIR and IADL-4 items [ Time Frame: Baseline visit, 18 months ]
- Quality of life evaluated by QOL-AD [ Time Frame: Baseline visit, 18 months ]
- Number of nursing staff's time off work [ Time Frame: 18 months ]Monthly collection during follow-up (18 months)
- Number of days off work by nursing staff [ Time Frame: 18 months ]Monthly collection during follow-up (18 months)
- Presence of advanced care planning in patients medical records [ Time Frame: Baseline visit, 18 months ]Advanced care planning will be checked through behavioural disosders, transfer to hospital intensive care and resuscitation
- Overall healthcare costs [ Time Frame: 18 months ]Monthly collection during follow-up (18 months)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Residents of both sex, aged 60 years or over
- Residents living in a nursing home participating in the study
- Residents living in the nursing home for 30 days or more
-
Residents without diagnosed and documented dementia, identified as follows:
- residents not identified by the French Healthcare system as suffering from dementia (ALD 15)
- residents not benefiting from a specific care program or a specialized follow-up for dementia
- residents for whom there is no appropriate investigation for dementia diagnosis in medical records
- residents not taking specific drugs for dementia (Cholinesterase inhibitors and/or Memantine)
- Residents and their GP having received information about the study
- Residents and their GP having expressed their agreement to participate in the study
Exclusion Criteria:
- Residents aged less than 60 years
- Residents not living in a nursing home participating in study
- Residents living in nursing home for less than 30 days
-
Residents with diagnosed and documented dementia, identified as follows:
- residents Identified by the French Healthcare system as suffering from dementia (ALD 15)
- residents benefiting from specific care programme or specialized follow-up for dementia
- residents for whom there is appropriate investigation for dementia diagnosis in medical records
- residents taking specific drugs for dementia (Cholinesterase inhibitors and/or Memantine)
- Residents and/or their GP who received no information about the study
- Residents and/or their GP having expressed their opposition to participate in the study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01569997

Principal Investigator: | Pierre ALLAN, MD | EHPAD MAISON DE RETRAITE SAINT JOSEPH - MAZAMET | |
Principal Investigator: | Véronique ARNAUD-ULLIET, MD | EHPAD MA MAISON MONTPELLIER |
Responsible Party: | University Hospital, Toulouse |
ClinicalTrials.gov Identifier: | NCT01569997 |
Other Study ID Numbers: |
0910701 2009-A01062-55 ( Other Identifier: ID-RCB ) |
First Posted: | April 4, 2012 Key Record Dates |
Last Update Posted: | July 29, 2020 |
Last Verified: | July 2020 |
Dementia emergency hospitalization nursing home multidisciplinary meeting cognitive decline disability |
residents facilities long term care unit health policy general practitioner prevention |
Dementia Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Neurocognitive Disorders Mental Disorders |